AlphaFold predicted structure
SCNM1 · Q9BWG6

Mean pLDDT
69.7/ 100
Low
230 residues
Confidence breakdown
- Very high(≥ 90)15%
- Confident(70–90)38%
- Low(50–70)20%
- Very low(< 50)27%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
sodium channel modifier 1
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLimb disorders
BIALLELIC, autosomal or pseudoautosomalSkeletal ciliopathies
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalorofaciodigital syndrome 19
neutropenia
Decreased total leukocyte count
myocardial infarction
coronary artery disorder
ischemic stroke
functional neutrophil defect
atopic eczema
hepatocellular carcinoma
orofaciodigital syndrome
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Sodium channel modifier 1
As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (PubMed:36084634). Plays a role in the regulation of primary cilia length and Hedgehog signaling (PubMed:36084634)
SCNM1 · Q9BWG6

Mean pLDDT
69.7/ 100
Low
230 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0